With the rise of peptide synthesis in recent years, many experts and researchers have predicted its success in the years to follow. If you look closely, the peptide synthesis market on a global level has three segments based upon the equipment, reagents & consumables, product name, and several others. Moreover, the equipment used in such a service is further analyzed throughout the four sub-segments, including lyophilizers, chromatography equipment, protein synthesizers, etc. The amount of research the experts have put towards the synthesis equipment manufacturing has significantly contributed to its growth.
Let’s take, for instance, researchers in February 2017, at MIT moved towards introducing brand-new equipment, which happened to enable a faster peptide synthesis process. It was a completely different prospect in the market than the equipment that already existed in the market. These researchers from MIT have ended up manufacturing the automated machine, which can help in forming links between amino acids under the time-frame of around 37 seconds. It, in turn, assists in generating more significant quantities of peptides in a short period.
However, consumables and reagents tend to generate massive revenue among other peptide synthesis goods and products. Moreover, recent developments made in peptide coupling reagents are expected to grow amid the market in the coming years.
If you look at the technology in today’s market, it can be classified into three vital segments – liquid phase peptide synthesis, solid-phase peptide synthesis, and hybrid technology. Furthermore, it is essential to know that the liquid phase peptide synthesis has taken over the global market in the entire forecast period. On the other hand, solid-phase peptide synthesis has experienced and registered considerable growth from 2019 and is projected to grow till 2026.
Integration and advancing automation amid the solid and liquid-phase services of custom peptide synthesis have contributed to reducing all the costs registered against peptide synthesis.
The application insights divide the market of peptide synthesis into the diagnosis, therapeutics, and research. The therapeutics segment’s revenue includes metabolic, cancer, respiratory, cardiovascular disorder, infectious diseases, GIT (gastrointestinal disorders), dermatology, pain, renal, CNS, and several others. Moreover, therapeutics‘ segments have taken the market by surprise and dominate the services of peptide synthesis applications in 2018. Experts also suggest that the trend might continue in the entire forecast period. Even the diagnosis segment can grow at a quick pace between 2020 to 2026. You can widely apply the synthesized peptides across various cancer treatments, which, in turn, has made a significant contributor out of this segment.
On the other hand, metabolic disorder segments can grow quickly throughout this subject forecast period. Also, such growth is attributed to a strong pipeline’s presence. When it comes to the newly discovered peptides that play an essential role amid metabolic regulations, you can expect them to produce pivotal insights in developing and designing impactful therapeutic approaches.
Talking about the current projection, the peptide synthesis market can reach around USD 426.4 million by the beginning of 2023 from a staggering figure of USD 310.5 million in 2018. Such an output is only possible at 6.5% CAGR because of several factors like relishing peptide used in pharmaceutical drugs, an increasing amount of research available, and activities of the R & D funding and the advanced peptide synthesizers’ development. This is primarily to drive the growth of the entire market.
Peptide synthesis projection
Peptides tend to be organic molecules that consist of amino acids accommodated or linked by an amide bond. It is generally a process to make short and meager sequences of peptides by the carboxyl group’s condensation reaction. Furthermore, you can segment the peptide synthesis market based on products cast into equipment and reagents. The equipment market can grow with a significant CAGR between 2018 and 2023. Also, experts and researchers use peptide synthesizers to process peptide synthesis among every piece of equipment available. The higher adoption rate of such equipment determines the growth in the current market.
In the forecast period, experts suggest that this industry would grow at a maximum rate in APAC. With considerable growth in previous years amid the research industry, India and China have been high-growth peptide synthesis markets. Even the research industry on these demographics has witnessed quite a lot in recent times.
With the shift in options and success, manufacturers nowadays focus on delivering worthwhile and established technologies to ensure sustainable and robust revenue growth. Moreover, experts anticipate that biotechnology-based drugs are the key drivers in the research industry. That’s because such a system can reflect the research’s increase with a rise in funds. With the forecast period playing a considerable role in peptide growth, it is just a matter of time, when peptide synthesis will experience a significant rise and success in the coming years.